DocGo Projects 12%-20% Revenue Growth for 2026

Reuters
11/11
DocGo Projects 12%-20% Revenue Growth for 2026

DocGo Inc. has issued its 2026 financial guidance, projecting a base business revenue increase of 12% to 20%. This forecast is based on already contracted revenues and does not include potential new acquisitions or contract wins. The company expects that, at the top end of this revenue range, it will exit 2026 with a positive adjusted EBITDA run rate. For the third quarter of 2025, DocGo reported total revenue of $70.8 million, a decrease from $138.7 million in the same period of 2024, primarily due to the wind-down of migrant-related programs. Excluding these programs, revenue increased by 8% to $62.4 million compared to $58.0 million in the third quarter of 2024. The company also noted that, with the exception of care gap closure and primary care offerings, all service lines are adjusted EBITDA positive on a contribution basis. Investment in care gap and primary care is expected to decline significantly in 2026 as early markets mature.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DocGo Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251110397776) on November 10, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10